GALR2, a pro-survival G-protein coupled receptor promoted angiogenesis via p38-mediated phosphorylation/inactivation of TTP, resulting in increased VEGF and IL-6 levels both in vitro in SCCHN cancer cells and in vivo in murine tumor xenografts and chorioallantoic membrane models [69]. Here, IL6 is linked to neoplasm.